Psychoactive Medication Prescribing After Critical Illness in American Adults Not Justified by a Documented Supporting Diagnosis
- 13 August 2026
- journal article
- research article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 54 (10) , 2555-2566
Abstract
OBJECTIVES: To describe psychoactive medication (PM) prescribing in the 30 days after an ICU admission requiring mechanical ventilation not supported by a documented diagnosis in American adults not prescribed a PM before ICU admission. This nondiagnostically supported PM prescribing was explored in patient subgroups and for up to 2 years. Design, Setting, and Patients: This retrospective cohort study analyzed data from the U.S. claims database PharMetrics Plus for Academics for adults admitted to an ICU requiring invasive mechanical ventilation between January 1, 2018, and December 31, 2019. Patients prescribed a PM or admitted to an ICU or long-term care facility in the year prior, or who ended insurance coverage during the index hospitalization, were excluded. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Common and uncommon diagnostic codes potentially justifying each PM class prescription were identified using a literature review and expert consensus. A total of 416 of 7898 patients (5.3%) were newly prescribed 484 PMs across four PM classes in the 30-day postdischarge period [193 anxiolytics (39.9%), 176 antidepressants (36.2%), 103 antipsychotics (21.3%), and 12 sleep aids (2.5%)]. A total of 207 prescriptions (42.8%) of these 484 PM prescriptions were not accompanied by a documented supporting diagnosis: 54 of 103 antipsychotics (52.4%), 88 of 193 anxiolytics (45.6%), 5 of 12 sleep aids (41.7%), and 60 of 176 antidepressants (44.1%). Patient subgroups significantly associated with greater 30-day PM prescribing not supported by a documented diagnosis were: younger than 65 (antipsychotics); no history of dementia (anxiolytics); a discharge to home (antidepressants, antipsychotics); and ICU readmission (sleep aids). New PM prescribing in the absence of a supporting documented diagnosis persisted over the next 2 years (31–90 d, 24.7%; 91–180 d, 37.8%; 181–365 d, 42.7%; 366–730 d, 36.6%) CONCLUSIONS: Although the prevalence of new PM prescribing to American ICU survivors in the 30 days after discharge is relatively low, nearly half is not supported by a documented diagnosis. Future prospective research should determine the prevalence of nondiagnostically documented PM prescribing that is unwarranted.Keywords
This publication has 57 references indexed in Scilit:
- Patient Characteristics and Practice Variation Associated With New Community Prescription of Benzodiazepine and z‐Drug Hypnotics After Critical Illness: A Retrospective Cohort Study Using the UK Clinical Practice Research DatalinkPharmacoepidemiology and Drug Safety, 2024
- Less inappropriate medication: first steps in medication optimization to improve post-intensive care patient recoveryIntensive Care Medicine, 2024
- Trends in and Factors Associated With Out-of-Pocket Spending for COVID-19 Hospitalizations From March 2020 to March 2021JAMA Network Open, 2022
- Effect of Medication Reconciliation at Hospital Admission on 30-Day Returns to HospitalJAMA Network Open, 2021
- The 5-year pre- and post-hospitalization treated prevalence of mental disorders and psychotropic medication use in critically ill patients: a Canadian population-based studyIntensive Care Medicine, 2021
- Treatment Indications for Antidepressants Prescribed in Primary Care in Quebec, Canada, 2006-2015JAMA, 2016
- Benzodiazepine-associated delirium in critically ill adultsIntensive Care Medicine, 2015
- Psychiatric Diagnoses and Psychoactive Medication Use Among Nonsurgical Critically Ill Patients Receiving Mechanical VentilationJAMA, 2014
- Cardiopulmonary resuscitation among mechanically ventilated patientsIntensive Care Medicine, 2014
- Three-Year Outcomes for Medicare Beneficiaries Who Survive Intensive CareJAMA, 2010